About us

Sciomics is active in early-phase development and translation of novel diagnostics for precision medicine focussing on cancer and organ failure.

Next to the internal development pipeline, Sciomics offers protein expression, phosphorylation and ubiquitination status analyses for drug target, disease mechanism and biomarker research in a CRO setting.

The immuno-based scioDiscover analyses more than 1,000 proteins and their modifications in a single assay.

Products and services

Sciomics offers a high-content analysis services for combined phosphorylation / ubiquitination and protein analysis to investigate pathway activity, disease mechanisms, drug mode-of-action or discover novel drug targets and biomarkers.

Currently, more than 1,000 proteins, many being keyplayers in biomedical pathways are analysed in parallel by our immuno-based antibody array platform. The platform guarantees robust and reproducible results which can easily be translated in clinical assays.

We support our partners and customers in their pre-clinical activities. In-depth know-how on pathway activities can speed up internal development activities providing insights to evaluate and benchmark novel compounds based on in-depth information on their mode-of-action as well as potential adverse effects.

In addition to the CRO activities, Sciomics is active in the early-phase development of novel diagnostics for precision medicine with a focus on cancer as well as organ failure.

scioPhospho - Protein and phosphorylation profiling

scioPhospho is a phosphorylation level and protein expression analysis service investigating 1,030 proteins in a single assay. The proteins are key players in the most important biomedical pathways. The analysis provides a comprehensive overview of pathway activities and the analysis service is highly valued by our customers for basic research questions as well as biomarker / target discovery, mode-of-action analysis and the elucidation of basic disease mechanisms.

Further reading

scioDiscover - Protein profiling service

scioDiscover is a protein expression analysis service investigating 1,030 proteins in a single assay. The proteins are key players in the most important biomedical pathways. Thereby, the analysis provides a very comprehensive overview of protein profiles in cells / tissues / body fluids such as plasma/serum or cerebrospinal fluid upon certain treatments or in different disease areas.

Further reading

Address
Sciomics GmbH
Karl-Landsteiner Str. 6
69151 Neckargemuend
Germany

Phone: +49 6221 4294830
Internet: www.sciomics.de
E-mail: Send message

Contact person

Christoph Schroeder
CEO
Phone: +49 6221 4294830
E-mail: Send message

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection